Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Remission With Interferon Based Therapy

NCT01490853 is registered in ClinicalTrials.gov with Università degli Studi di Brescia as lead sponsor.

NCT NCT01490853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Remission With Interferon Based Therapy
Lead sponsor
Università degli Studi di Brescia
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2014
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia